|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 970 DKK | -0.34% |
|
+0.41% | +38.95% |
| 11:17am | Novo Nordisk's Main Owner Leads $100 Million Financing of Biotech Firm Asceneuron | DJ |
| 09:00am | Novo owner backs Swiss biotech Asceneuron in $100 million round | RE |
NOVO NORDISK: EXPECTS U.S. FDA DECISION ON SELECT EXPANDED LABEL BY END OF FIRST HALF OF 2024
| 1st Jan change | Capi. | |
|---|---|---|
| +38.95% | 631B | |
| +62.02% | 856B | |
| -4.16% | 359B | |
| +15.53% | 325B | |
| +9.20% | 297B | |
| +5.89% | 234B | |
| +16.53% | 226B | |
| +16.06% | 177B | |
| +2.39% | 165B | |
| +2.41% | 126B |
NOVO NORDISK A/S 
